CoChat

Smoking Acutely Increases Plasma Ghrelin Concentrations

Bouros, Demosthenes, Tzouvelekis, Argyris, Anevlavis, Stavros, Doris, Michael, Tryfon, Stavros, Froudarakis, Marios, Zournatzi, Vasiliki, Kukuvitis, Asterios · 2006 · Clinical Chemistry
Cited by 54

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Smoking and smoking cessation are associated with weight changes (1), and many smokers give weight gain as a primary reason for not trying to quit smoking (2). A relationship has been reported between smoking and plasma concentrations of ghrelin, a 28-amino acid growth hormone–releasing peptide secreted mainly by the stomach (3)(4)(5). Our primary aim was to determine whether smoking has an acute effect on plasma ghrelin concentrations. We enrolled 36 healthy volunteers, 28 men [mean (SD) age, 28.4 (7.5) years] and 8 women [30.4 (9.8) years]; 26 volunteers were smokers and 10 were nonsmokers. The study was approved by the Ethics Committee of our institution, and informed, written consent was obtained from each participant. None of the individuals had a history of gastric surgery or any serious health problems. Smoking history and body mass index (BMI) were determined for all participants. Blood samples were collected after overnight fasting, and plasma was frozen in aliquots at −80 °C immediately after centrifugation (1600g for 15 min at 4 °C). We measured ghrelin with an enzyme immunoassay (Phoenix Pharmaceuticals). The intraassay CV was <5%, the interassay CV was <14%, and the lower detection limit was 0.1 μg/L. The participants smoked 1 filtered cigarette containing 0.8 mg of nicotine under highly regulated conditions. Every 15 s, a puff lasting 5 s was taken, and the whole cigarette had to be smoked within 5 min. Plasma ghrelin concentrations were determined at 0, 2, 5, 15, and 60 min after the initiation of smoking. We used the Student t-test to compare the mean values for the studied groups. Significance between groups was set at P = 0.05. The mean (SD) plasma concentrations for baseline and at 2, 5, 15, and 60 min are shown in Fig. 11 . We observed significant increases (P <0.001) from baseline at 2, 5, and 15 min after smoking. A separate analysis revealed that increases occurred in both smokers and nonsmokers. In general, peak values were observed at 2 min (Fig. 11 ). Baseline mean values for smokers did not differ significantly from those for nonsmokers. We observed no significant difference in mean (SD) BMI between men [25.8 (2.5) kg/m2] and women [23.4 (5.1) kg/m2; P = 0.73] or between smokers [25.8 (3.2) kg/m2] and nonsmokers [23.7 (3.3) kg/m2; P = 0.1]. This study demonstrates the acute effect of cigarette smoking on plasma concentrations of the novel orexigenic hormone ghrelin. The most interesting finding of this study was the unexpected increase in ghrelin concentrations shortly after smoking. The effect of smoking 1 cigarette continued for at least 15 min and was independent of the BMI of each individual. The most intense increase was noted 2 min after smoking initiation. Given the known anorexic action of smoking (6), a decrease in ghrelin concentrations might be expected as an acute effect of smoking. Alcohol has also exhibited an unexpected acute inhibitory effect on ghrelin secretion in healthy individuals, despite its strong orexigenic influence in humans (7). We speculate that this acute increase of ghrelin during smoking is related to adverse effects on gastric mucosa, gastric motility, mucosal blood flow, and concentrations of free radicals (8). Enhancement of ghrelin secretion could also be an indirect influence mediated by other factors, including growth hormone (nicotine increases the growth hormone concentration) (9), leptin (inverse correlation with ghrelin concentrations) (10), and vagal nerve stimulation (smoking affects vagal nerve activity) (11). Our finding that smoking is more likely to produce an acute release of intracellular ghrelin into the circulation rather than a time- or dose-dependent stomach secretion is partially in agreement with the hypothesis of investigators (4)(5) that circulating ghrelin concentrations are related to the time elapsed after smoking. Rather than being definitive, however, our observations may also lead to hypotheses for future research. In conclusion, the findings of this study provide evidence that smoking affects hormones that influence the appetite, specifically ghrelin. Further studies are warranted to clarify the effect of smoking on various gut hormones to explain the weight disturbances associated with smoking cessation. Mean (SD) plasma ghrelin concentrations (μg/L) after cigarette smoking for all study participants. ∗∗, P = 0.0005; ∗, P <0.001; NS, not significant. We have no financial relationship with any commercial entity that has an interest in the subject of this letter. We are grateful to George Zacharis, MD, for valuable assistance in enrolling healthy volunteers for our project.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2005.065243

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 54

Metadata

Authors
Bouros, D., Tzouvelekis, A., Anevlavis, S., Doris, M., Tryfon, S., Froudarakis, M., Zournatzi, V., & Kukuvitis, A.
Venue
Clinical Chemistry
Published
2006-04-01
Volume
52
Issue
4
Pages
777-778
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W1997928317
Cited by
54
References
2
FWCI
0.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.